Research Study

Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment
Principal Investigator 
Philip A. Teal

Overview

Body Locations and Systems 
Stroke
ClinicalTrials.gov# 
NCT00465270
Status 
Closed to Recruitment
Study Start/End 
Sep 23, 2009 to Sep 23, 2017
Locations 
Vancouver General Hospital
Name/Title 
Karina Villaluna Murray, Research Coordinator
Phone 
604-875-4554
Purpose of Study 

The purpose of this study is to investigate whether percutaneous Patent Foramen Ovale (PFO) closure, using the AMPLATZER PFO Occluder, is superior to current standard of care medical treatment in the prevention of recurrent embolic stroke.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.